Phase 2 biotech developing CAR T cell therapies for multiple myeloma.
Industry: Health Care
First Day Return: -4.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/19/2020 |
Offer Price | $16.00 |
Price Range $16.00 - $16.00 | |
Offer Shares (mm) | 14.0 |
Deal Size ($mm) | $224 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/09/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $224 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2003 |
Employees at IPO | 149 |
Website www.poseida.com |